mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |